Responsiveness to inhaled NO in isolated-perfused lungs from endotoxin-challenged rats is dependent on endogenous nitrite/nitrate synthesis

European Journal of Anaesthesiology

Volumn 24, Issue 4, 2007, Pages 362-369

  Bopp, Ch ^a   Gust, R ^a   Taut, F ^a   Gries, A ^a   Martin, E ^a   Klein, Alexandra ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adult; Endotoxins; Lipopolysaccharides; Nitric oxide; Nitric oxide synthase type 2; Rat; Respiratory distress syndrome

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; AMINOGUANIDINE; ENDOTOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; METHYLISOTHIOUREA; NITRATE; NITRIC OXIDE; NITRITE; THIOUREA DERIVATIVE; THROMBOXANE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG RESPONSE; ISOLATED LUNG; LUNG ARTERY PRESSURE; LUNG PERFUSION; MODULATION; NONHUMAN; PROVOCATION TEST; RAT; SERUM; SPRAGUE DAWLEY RAT; VASODILATATION;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANIDINES; ISOTHIURONIUM; LIPOPOLYSACCHARIDES; LUNG; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33847124864     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506001463     Document Type: Article

References (33)

1. Rossaint R, Falke KJ, Lopez F et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328(6): 399-405.
2. Bigatello LM, Hurford WE, Kacmarek RM et al. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome - effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994; 80: 761-770.
3. Krafft P, Fridrich P, Fitzgerald RD et al. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996; 109: 486-493.
4. Holzmann A, Bloch KD, Sanchez LS et al. Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. Am J Physiol 1996; 271: L981-L986.
5. Nakayama DK, Geller DA, Lowenstein CL et al. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am J Respir Cell Mol Biol 1992; 7: 471-476.
6. Geller DA, Nussler AK, Silvio MD et al. Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993; 90: 522-526.
7. Liu SF, Crawley DE, Rohde JA et al. Role of nitric oxide and guanosine 3′-5′-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Br J Pharmacol 1992; 107(3): 861-866.
8. Holzmann A, Manktelow C, Taut FJH et al. Inhibition of nitric oxide synthase prevents hyporesponsiveness to inhaled nitric oxide in lungs from endotoxin-challenged rats. Anesthesilogy 1999; 91: 215-221.
9. Szabo C, Ferrer-Sueta G, Zingarelli B et al. Mercaptoethylguanidine and guanidine inhibitors of nitric oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 1997; 272: 9030-9036.
10. Giardino I, Fard AK, Hatchell DL et al. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation and oxidant-induced apoptosis. Diabetes 1998; 47: 1114-1120.
11. Oudkerk Pool M, Bouma G, Visser JJ et al. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1995; 30: 784-788.
12. Dellinger RP, Zimmerman JL, Taylor RW et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome. Crit Care Med 1999; 26: 15-23.
13. MacNaul KL, Hutchinson NI. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 1993; 196: 1330-1334.
14. Wong HR, Carcillo JA, Burckart G et al. Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Crit Care Med 1995; 23(5): 835-842.
15. Gutierrez HH, Pitt BR, Schwarz M et al. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am J Physiol 1995; 268: L501-L508.
16. Arkowitz MS, Wispe JR, Garcia VF et al. Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J Pediatr Surg 1996; 31: 1009-1015.
17. Doursout MF, Hartley CJ, Chelly JE. Comparison of cardial and regional hemodynamic responses to N-methyl-L-arginine and aminoguanidine infusions in conscious pigs. J Cardiovasc Pharmacol 2001; 37: 349-358.
18. Griffiths MJD, Messent M, MacAllister RJ et al. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993; 110: 963-968.
19. Arkowitz MS, Wispe JR, Garcia VF et al. Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular during acute enotoxemia. J Pediatr Surg 1996; 31: 1009-1015.
20. Hayashi Y, Abe M, Murai A et al. Comparison of effects of nitric oxide synthase (NOS) inhibitors on plasma nitrite/nitrate levels and tissue NOS activity in septic organs. Microbiol Immunol 2005; 49: 139-147.
21. Weimann J, Bloch KD, Takata M et al. Congenital NOS2 deficiency protects mice from LPS-induced hyporesponsiveness to inhaled nitric oxide. Anesthesiology 1999; 91: 1744-1753.
22. Combs X, Mazmanian M, Gourlain H et al. Effect of 48 hours of nitric oxide inhalation on pulmonary vasoreactivity in rats. Am J Resp Crit Care Med 1997; 156: 473-477.
23. Frank DU, Horstman DJ, Morris GN et al. Regulation of the endogenous NO pathway by prolonged inhaled NO in rats. J Appl Physiol 1998; 85: 1070-1078.
24. Roos CM, Frank DU, Xue C et al. Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats. J Appl Physiol 1996; 80: 252-260.
25. Radi R, Beckman JS, Bush KM et al. Peroxynitrite oxidation of sulfhydryls - the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266(7): 4244-4250.
26. Giardino I, Fard AK, Hatchell DL et al. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation and oxidant-induced apoptosis. Diabetes 1998; 47: 1114-1120.
27. Wolff DJ, Gauld DS, Neulander MJ et al. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas. J Pharmacol Exp Ther 1997; 283: 265.
28. Jang D, Szabo C, Murrell GA. S-substituted isothioureas are potent inhibitors of nitric oxide biosynthesis in cartilage. Eur J Pharmacol 1996; 312: 341-347.
29. Wolfard A, Kaszaki J, Szabo C et al. Effects of selective nitric oxide synthase inhibition in hyperdynamic endotoxemia in dogs. Eur Surg Res 1999; 31: 314-323.
30. Rosselet A, Feihl F, Markert M et al. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Resp Crit Care Med 1998; 157: 162-170.
31. Numata M, Suzuki S, Miyazawa N et al. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol 1998; 160: 3031-3037.
32. Sartorio CL, Pinto VD, de Sallas Cutini GJ et al. Effects of inducible nitric oxide synthase inhibition on the rat tail vascular bed reactivity three days after myocardium infarction. J Cardiovasc Pharmacol 2005; 45: 321-326.
33. Lee CC, Lin NT, Hsu YH et al. Inducible nitric oxide synthase inhibition potentiates multiple organ dysfunction by endotoxin in conscious rats. J Cardiovasc Pharmacol 2005; 45: 396-403.